Material Agreements

Health Catalyst, Inc. entered into Unit Purchase Agreement with Med-Metrix, LLC valued at $147 million (effective 2026-06-04).

“On June 4, 2026, Health Catalyst, Inc. ("Health Catalyst") entered into a Unit Purchase Agreement (the "Purchase Agreement") with Med-Metrix, LLC ("Buyer")”

Warner Bros. Discovery, Inc. entered into First Lien Credit Agreement valued at $13,000 million (effective 2026-06-04).

“On June 4, 2026, Discovery Global Holdings, Inc. (“DGH”), a wholly-owned subsidiary of Warner Bros. Discovery, Inc. (the “Company”), entered into that certain First Lien Credit Agreement (the “First Lien Credit Agreement”) among the Company, as holdco, DGH, as parent borrower, the designated subsidiary borrowers from time to time party thereto, the lenders from time to time party thereto, JPMorgan Chase Bank, N.A. (“JPM”), as U.S. administrative agent and collateral agent, and J.P. Morgan SE, as non-U.S. administrative agent.”

Hilton Grand Vacations Inc. entered into Underwriting Agreement with Selling Stockholders, Wells Fargo Securities, LLC (as Representative) (effective 2026-06-02).

“On June 2, 2026, Hilton Grand Vacations Inc. (the “Company”), and certain entities managed by affiliates of Apollo Global Management, Inc. (the “Selling Stockholders”), entered into an Underwriting Agreement (the “Underwriting Agreement”) with Wells Fargo Securities, LLC (the “Representative”), as representative of the several underwriters (the “Underwriters”), in connection with the offer and sale by the Selling Stockholders (the “Offering”) of 5,000,000 shares of the Company’s common stock”

VisionWave Holdings, Inc. entered into Securities Exchange Agreement with Foresight Autonomous Holdings Ltd. valued at $17,500,000 (effective 2026-06-02).

“On June 2, 2026, VisionWave Holdings, Inc. (the “Company”) entered into a Securities Exchange Agreement (the “Foresight Agreement”) with Foresight Autonomous Holdings Ltd. (“Foresight”), pursuant to which the Company will acquire, in two stages, newly issued ordinary shares of Foresight representing 52% of Foresight’s issued and outstanding share capital as of the Stage 1 Closing”

MIRA PHARMACEUTICALS, INC. amended Amended and Restated Exclusive License Agreement with MIRALOGX LLC (effective 2026-06-03).

“On June 3, 2026, MIRA Pharmaceuticals, Inc. (the "Company") entered into an Amended and Restated Exclusive License Agreement (the "License Agreement") with MIRALOGX LLC ("Miralogx").”

Imunon, Inc. entered into Securities Purchase Agreement with Streeterville Capital, LLC valued at Total financing of $10,000,000; issuance of 250 shares of Series A Preferred Stock at $10,000 per sh (effective 2026-06-02).

“On June 2, 2026, Imunon, Inc. (the “ Company ”) entered into a securities purchase agreement (the “ Securities Purchase Agreement ”) with Streeterville Capital, LLC (the “ Investor ”), providing for the issuance and sale by the Company, and the purchase by the Investor, of (i) 250 shares (the “ Preferred Shares ”) of the Company’s Series A Preferred Stock, par value $0.01 per share (the “ Series A Preferred Stock ”), at a price of $10,000 per share, for aggregate proceeds of $2,500,000; (ii) a Secured Promissory Note A-1 in an original principal amount of $2,720,000 (the “ A-1 Note ”); and (iii) a Secured Promissory Note B in an original principal amount of $5,000,000 (the “ B Note ” and together with the A-1 Note, the “ Notes ”).”

CONMED Corp entered into Purchase Agreements with certain holders of its 2.25% Convertible Senior Notes due 2027 valued at approximately $645.2 million aggregate principal amount of Notes from the holders thereof for approx (effective 2026-06-03).

“On June 3, 2026, CONMED Corporation, a Delaware corporation (“ CONMED ”), entered into separate, privately negotiated purchase agreements (the “ Purchase Agreements ”) with certain holders of its 2.25% Convertible Senior Notes due 2027 (the “ Notes ”). Under the terms of the Purchase Agreements, the Company agreed to purchase approximately $645.2 million aggregate principal amount of Notes from the holders thereof for approximately $637.2 million in cash.”

Syndax Pharmaceuticals Inc entered into Indenture with U.S. Bank Trust Company, National Association valued at $250.0 million aggregate principal amount of 2.25% Convertible Senior Notes due 2031 (effective 2026-06-03).

“On June 3, 2026, Syndax Pharmaceuticals, Inc. (the “ Company ”) entered into privately negotiated subscription agreements (the “ Subscription Agreements ”) with certain investors, pursuant to which the Company will issue $250.0 million aggregate principal amount of 2.25% Convertible Senior Notes due 2031 (the “ Notes ”).”

NextTrip, Inc. entered into Monaco Loans with The Donald P. Monaco Insurance Trust valued at $200,000 (effective 2026-05-29).

“On May 29, 2026, NextTrip, Inc. (the “Company”) borrowed on a short- term basis the amount of $200,000 (the “May 29 Loan”) from The Donald P. Monaco Insurance Trust (the “Trust”).”

Atkore Inc. entered into Settlement Agreement with End User Plaintiffs valued at $50 million (effective 2026-06-03).

“On June 3, 2026 the Company entered into a settlement agreement (the "Settlement Agreement") with the third putative class in the Class Action Litigation — the End User Plaintiffs ("End User Plaintiffs"), individually and on behalf of the putative End User Plaintiff class members.”

MARSH & MCLENNAN COMPANIES, INC. terminated Amended and Restated 5 Year Credit Agreement with Citibank, N.A., as administrative agent, and the lenders from time to time party thereto valued at $3.5 billion (effective 2026-06-02).

“In connection with the New Facility, on June 2, 2026, the Company terminated its multi-currency unsecured $3.5 billion five-year revolving credit facility under the Amended and Restated 5 Year Credit Agreement, dated as of October11, 2023, among the Company, as borrower, the designated subsidiaries party thereto, as borrowers, Citibank, N.A., as administrative agent, and the lenders from time to time party thereto.”

MARSH & MCLENNAN COMPANIES, INC. entered into Amended and Restated 5 Year Credit Agreement with Citibank, N.A., as administrative agent, and the lenders from time to time party thereto valued at $4.25 billion (effective 2026-06-02).

“On June 2, 2026, Marsh & McLennan Companies, Inc. (the “Company”) and certain of its domestic and foreign subsidiaries entered into a new Amended and Restated 5 Year Credit Agreement, dated as of June 2, 2026, among the Company, as borrower, the designated subsidiaries party thereto as borrowers, Citibank, N.A., as administrative agent, and the lenders from time to time party thereto (the “Credit Agreement”).”

LIGHTPATH TECHNOLOGIES INC entered into Placement Agent Agreement with Craig-Hallum Capital Group LLC (effective 2026-06-01).

“The Company also entered into a placement agency agreement (the “Placement Agent Agreement”) with the Selling Stockholder and Craig-Hallum Capital Group LLC, as the sole placement agent (the “Placement Agent”), dated June 1, 2026”

LIGHTPATH TECHNOLOGIES INC entered into Securities Purchase Agreement with North Run Strategic Opportunities Fund I, LP valued at approximately $50.0 million (effective 2026-06-01).

“On June 1, 2026, LightPath Technologies, Inc., a Delaware corporation (the “Company”), entered into a securities purchase agreement (the “Securities Purchase Agreement”) with North Run Strategic Opportunities Fund I, LP (the “Selling Stockholder”) and certain institutional investors for the purchase and sale of an aggregate of 7,142,800 shares of the Company’s Class A Common Stock”

DevvStream Corp. entered into Term Sheet with EEME Energy SPV I, LLC valued at $6,000,000 (effective 2026-06-03).

“On June 3, 2026, DevvStream Corp. (the "Company") entered into a binding term sheet (the "Term Sheet") with EEME Energy SPV I, LLC (the "Investor") for a private placement of the Company's Series A Non-Redeemable Convertible Preferred Stock (the "Series A Preferred Stock") in an aggregate investment amount of $6,000,000 (the "Transaction").”

Sports Entertainment Gaming Global Corp entered into Securities Purchase Agreement with Amorua Global, Inc. valued at $3,500,000 (effective 2026-05-26).

“On May 26, 2026 (the “Closing Date”), Sports Entertainment Gaming Global Corporation (the “Company”) entered into a Securities Purchase Agreement (the “Purchase Agreement”) with Amorua Global, Inc. (“Amorua” or the “Investor”), pursuant to which the Company issued to the Investor an unsecured convertible promissory note (the “Note”) in an original principal amount of $3,500,000.”

Charlotte's Web Holdings, Inc. amended "Amended & Restated IRA" with BT DE Investments Inc. ("BAT") (effective 2026-05-28).

“on May 28, 2026, the Company and BAT amended and restated the Restated Investor Rights Agreement (as amended and restated, the “Amended & Restated IRA”)”

Charlotte's Web Holdings, Inc. amended "Amendment and Conversion Notice" with BT DE Investments Inc. ("BAT") (effective 2026-05-28).

“on May 28, 2026, the Company and BAT entered into an amendment and conversion notice (the “Amendment and Conversion Notice”) for the Convertible Debenture”

Liminatus Pharma, Inc. entered into Inducement Letter Agreement with a holder of its existing common stock warrants valued at $1,861,920.00 (effective 2026-06-03).

“On June 3, 2026, Liminatus Pharma, Inc. (the “Company”) entered into a warrant exercise inducement offer letter (the “Inducement Letter Agreement”) with a holder (the “Holder”) of its existing common stock warrants”

AMTECH SYSTEMS INC entered into Underwriting Agreement with Titan Partners Group LLC, a division of American Capital Partners, LLC valued at aggregate gross proceeds of approximately $60 million (effective 2026-06-01).

“On June 1, 2026, Amtech Systems, Inc. (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) with Titan Partners Group LLC, a division of American Capital Partners, LLC (the “Underwriter”), pursuant to which the Company agreed to issue and sell in an underwritten public offering (the “Offering”) an aggregate of 2,926,829 shares of its common stock, par value $0.01 per share (“Common Stock”), at a price to the public of $20.50 per share for aggregate gross proceeds of approximately $60 million, less underwriting discounts and commissions and offering expenses.”

CXApp Inc. entered into Share Sale Deed with Virtus Digital Marketing Pty Ltd dba Engine Room Applications valued at approximately USD $4.6 million (effective 2026-06-03).

“On June 3, 2026, CXApp Inc.’s (“CXAI” or the “Company”) wholly owned subsidiary, CXAI Australia Pty Ltd (a company incorporated in Australia) (“CXAI Australia”), entered into and completed a Share Sale Deed (the “Agreement”) to acquire Virtus Digital Marketing Pty Ltd dba Engine Room Applications.”

Blackstone Multi-Strategy Hedge Fund L.P. entered into Dealer Manager Agreement with Blackstone Securities Partners L.P. (effective 2026-05-28).

“On May 28, 2026, Blackstone Multi-Strategy Hedge Fund L.P. (the “ Fund ”) and its affiliate, Blackstone Multi-Strategy Hedge Fund Offshore SPC (the “ Offshore Fund ” and together with the Fund, “ BXHF ”), entered into a dealer manager agreement (the “ Dealer Manager Agreement ”) with Blackstone Securities Partners L.P. (the “ Dealer Manager ”), an affiliate of BXHF.”

Hall Chadwick Acquisition Corp entered into Business Combination Agreement with REEcycle Holdings, Inc. valued at Entry into a Business Combination Agreement for HCAC to domesticate as a Delaware corporation and me (effective 2026-05-31).

“On May 31, 2026, Hall Chadwick Acquisition Corp, a Cayman Islands exempted company limited by shares, with registration number 421976 (“ HCAC ”), entered into a Business Combination Agreement (the “ Business Combination Agreement ”) with HCAC Star Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of HCAC (“ Merger Sub ”), and REEcycle Holdings, Inc., a Delaware corporation (“ REEcycle ”), a rare earth elements recycling company focused on the recovery of rare earths from end-of-life magnets using innovative hydrometallurgical technique to produce market-grade rare earth oxides and salts that can feed directly into magnet alloy manufacturing.”

ESCO TECHNOLOGIES INC terminated Existing Credit Agreement with JPMorgan Chase Bank, N.A. as Administrative Agent, Bank of America, N.A. as Syndication Agent, Commerce Bank and TD Bank, N.A. as Co-Documentation Agents, and the Departing Lenders.

“which as noted below, will be terminated on the Acquisition Closing Date upon the effectiveness of the New Credit Agreement.”

ESCO TECHNOLOGIES INC entered into New Credit Agreement with a group of banks led by JPMorgan Chase Bank, N.A. as administrative agent, Bank of America, N.A. as syndication agent, BMO Capital Markets Corp., Commerce Bank, Regions Capital Markets, a Division of Regions Bank, TD Bank, N.A. and Wells Fargo Bank, National Association as co-documentation agents valued at initial aggregate commitment amount of $500 million (effective 2026-05-29).

“On May 29, 2026, the Registrant and certain of its subsidiaries entered into Credit Agreement with a group of banks led by JPMorgan Chase Bank, N.A. as administrative agent, Bank of America, N.A. as syndication agent, BMO Capital Markets Corp., Commerce Bank, Regions Capital Markets, a Division of Regions Bank, TD Bank, N.A. and Wells Fargo Bank, National Association as co-documentation agents (the "New Credit Agreement").”

TREASURE GLOBAL INC entered into Software Development Agreement with Nexe Cloud Limited valued at US$300,000.00 (effective 2026-05-28).

“On May 28, 2026, Treasure Global Inc, a Delaware corporation (the “Company”), entered into a Software Development Agreement (the "Agreement") with Nexe Cloud Limited, a company incorporated under the laws of the British Virgin Islands (the “Developer”).”

Tribeca Strategic Acquisition Corp. entered into Underwriting Agreement with BTIG, LLC valued at $140,000,000 (effective 2026-05-28).

“An Underwriting Agreement, dated May 28, 2026 (the “Underwriting Agreement”), by and between the Company and BTIG, LLC, as representative of the underwriters named therein”

CytomX Therapeutics, Inc. amended Amendment No. 4 with Regeneron Pharmaceuticals, Inc. valued at Total potential target nomination payments and preclinical, clinical, regulatory and commercial mile (effective 2026-05-31).

“On May 29, 2026, the Company and Regeneron entered into Amendment No. 4 to the Agreement (“Amendment No. 4”), effective May 31, 2026”

FONAR CORP entered into Credit Agreement with OceanFirst Bank, N.A. valued at term loan facility in an aggregate principal amount equal to $20 million and a revolving credit faci.

“Credit Agreement In connection with the Closing, Parent and the Company (as successor in interest to Merger Sub by way of the Merger), as borrowers, entered into a Credit Agreement with OceanFirst Bank, N.A., as lender, and each other borrower from time to time joined as party thereto (the “ Parent Credit Agreement ”), which provides for (i) a term loan facility in an aggregate principal amount equal to $20 million and (ii) a revolving credit facility in an aggregate principal amount equal to $15 million.”

Fathom Holdings Inc. amended Limited Waiver and Omnibus Amendment to the Senior Secured Convertible Promissory Notes with two accredited investors (effective 2026-05-29).

“On May 29, 2026, the Company and the Holders entered into a Limited Waiver and Omnibus Amendment to the Senior Secured Convertible Promissory Notes (the “Waiver”).”

Fathom Holdings Inc. amended Amended and Restated Bridge Note with Bed Bath & Beyond, Inc. valued at aggregate original principal amount of $3,036,350 (effective 2026-05-29).

“On May 29, 2026, the parties to the Original Bridge Note agreed to amend and restate the Original Bridge Note (the “Amended and Restated Bridge Note”) to, among other things, increase the original principal amount by $1,000,000 (the “Additional Principal Amount”), for an aggregate original principal amount of $3,036,350, including $36,350 of accrued interest on the original principal amount as of May 29, 2026.”

FS KKR Capital Corp amended Ninth Amendment to Loan and Servicing Agreement with Sumitomo Mitsui Banking Corporation (effective 2026-06-01).

“On June 1, 2026, CCT Tokyo Funding LLC (“CCT Tokyo”), a wholly owned subsidiary of FS KKR Capital Corp. (the “Company”), entered into a Ninth Amendment to Loan and Servicing Agreement (the “Ninth Amendment”), which amends that certain Loan and Servicing Agreement, dated as of December 2, 2015, by and among CCT Tokyo, as borrower, the Company, as servicer, Sumitomo Mitsui Banking Corporation, as administrative agent and lender (the “Administrative Agent”), and the other parties thereto.”

Chain Bridge I amended Amendment No. 1 with C/M Capital Master Fund LP (effective 2026-05-28).

“On May 28, 2026, the Chain Bridge I (the “Company”) entered into Amendment No. 1 (the “Amendment No. 1”) to the unsecured, non-interest bearing promissory note in the aggregate amount of $1,250,000 (the “Senior Note”), originally issued on September 30, 2025, held by C/M Capital Master Fund LP (the “Existing Lender”).”

Lord Abbett Private Credit Fund amended Second Amendment with Royal Bank of Canada valued at $450,000,000 (effective 2026-06-01).

“On June 1, 2026 (the “Closing Date”), Lord Abbett PCF Financing 2 LLC (“PCF Financing 2”), a wholly-owned, special purpose financing subsidiary of Lord Abbett Private Credit Fund (“we,” the “Company,” or the “Fund”), entered into Amendment No. 2 (“Second Amendment”) to the Loan and Security Agreement (the “Loan Agreement”), by and among PCF Financing 2, as borrower, the Company, as collateral manager, Royal Bank of Canada (“RBC”) as administrative agent, each of the lenders from time to time party thereto, and Computershare Trust Company, N.A., as collateral agent and collateral custodian.”

DevvStream Corp. terminated Purchase Agreement with Helena Global Investment Opportunities I LTD., Focus Impact Sponsor, LLC (effective 2026-06-03).

“On June 3, 2026, DevvStream Corp. (the “Company”) terminated that certain Purchase Agreement (the “Agreement”) dated as of October 29, 2024, by and between the Company, Helena Global Investment Opportunities I LTD. (the “Investor”), and Focus Impact Sponsor, LLC, a Delaware limited liability company, in accordance with the terms of the ELOC Agreement.”

HEALTHY CHOICE WELLNESS CORP. entered into Exchange Agreement with certain holders of the Company’s indebtedness valued at $1,431,000 of principal (effective 2026-05-28).

“On May 28, 2026, Healthy Choice Wellness Corp. (the “Company”) entered into an agreement (an “Exchange Agreement”) with certain holders (the “Holders”) of the Company’s indebtedness (the “Notes”) to exchange in an aggregate amount of $1,431,000 of principal of the Notes for 5,315,450 shares of the Company’s Class A common stock (the “Common Stock”) at a price per share of $0.27 (the “Exchange”).”

Kingfish Holding Corp amended Loan Extension with Hancock Whitney Bank (effective 2026-05-29).

“On May 29, 2026, 6 LLC, a Florida limited liability company (“6 LLC”), entered into a loan extension (the “Loan Extension”) with Hancock Whitney Bank (“Hancock Whitney”) to extend the existing loan between 6 LLC and Hancock Whitney to August 18, 2026 (as amended, the “Hancock Whitney Loan”).”

Benchmark 2026-V22 Mortgage Trust entered into Pooling and Servicing Agreement with Citigroup Commercial Mortgage Securities Inc. valued at Issuance of Commercial Mortgage Pass-Through Certificates, Series 2026-V22 (effective 2026-05-26).

“On May 26, 2026 (the “ Closing Date ”), Benchmark 2026-V22 Mortgage Trust (the “ Issuing Entity ”) issued the Benchmark 2026-V22 Mortgage Trust, Commercial Mortgage Pass-Through Certificates, Series 2026-V22, pursuant to a Pooling and Servicing Agreement, dated as of May 1, 2026 (the “ Pooling and Servicing Agreement ”), between Citigroup Commercial Mortgage Securities Inc., as depositor, Trimont LLC, as master servicer, LNR Partners, LLC, as special servicer, BellOak, LLC, as operating advisor and as asset representations reviewer, Citibank, N.A., as certificate administrator, and Wilmington Savings Fund Society, FSB, as trustee.”

KKR FS Income Trust amended Third Amendment to Senior Secured Revolving Credit Agreement with Sumitomo Mitsui Banking Corporation, as administrative agent and collateral agent, and the lenders and issuing banks party thereto valued at $750,000,000 (effective 2026-05-28).

“On May 28, 2026, KKR FS Income Trust (the “Company”), together with the subsidiary guarantors party thereto, entered into a Third Amendment to Senior Secured Revolving Credit Agreement (the “Third Amendment”) to the Senior Secured Revolving Credit Agreement, dated as of July 19, 2023 (as previously amended by that certain First Amendment to Senior Secured Revolving Credit Agreement, dated as of January 26, 2024, and that certain Second Amendment to Senior Secured Revolving Credit Agreement, dated as of March 17, 2026, the “Credit Agreement”), by and among the Company, as borrower, the subsidiary guarantors party thereto, the lenders and issuing banks from time to time party thereto, and Sumitomo Mitsui Banking Corporation, as administrative agent and collateral agent.”

Inotiv, Inc. entered into Restructuring Support Agreement with Consenting Stakeholders (Consenting First Lien Lenders, Consenting PIK Noteholders, Consenting Unsecured Convertible Noteholders) (effective 2026-06-02).

“On June 2 2026, the Company entered into a Restructuring Support Agreement (together with all exhibits and schedules thereto, the “Restructuring Support Agreement”) with: · certain lenders, or investment advisors, or holders of claims pursuant to the Company’s obligations under that certain credit agreement, dated as of November 5, 2021”

Sintx Technologies, Inc. entered into Partner Capital Agreement with Partner Capital Group, LLC (effective 2026-04-06).

“On April 6, 2026, the Company entered into a Confidential and Proprietary Information Agreement (the “Partner Capital Agreement”) with Partner Capital Group, LLC (“Partner Capital”), pursuant to which Partner Capital acted as non-exclusive marketing and consulting representative to represent the Company for an initial three (3) months term from the date of this Agreement (the “Initial Term”) in a potential bona fide capital raising transaction involving the offer and sale of equity, equity-linked or debt securities of the Company to financial investors for the primary purpose of raising capital.”

Sintx Technologies, Inc. entered into Securities Purchase Agreement with certain accredited investors valued at approximately $4.5 million (effective 2026-06-02).

“On June 2, 2026, SINTX Technologies, Inc. (the “Company”) entered into a Securities Purchase Agreement (the “Purchase Agreement”) with certain accredited investors (the “Purchasers”) pursuant to which the Company agreed to sell in a private placement (the “Offering”) an aggregate of 1,882,845 units (the “Units”) at a purchase price of $2.39 per Unit for aggregate gross proceeds of approximately $4.5 million, before deducting fees and offering expenses.”

Quantum Cyber N.V. amended Amendment No. 1 to Intellectual Property License Agreement with BP United Inc. (effective 2026-06-01).

“On June 1, 2026, Quantum Cyber N.V. (the “Company”) entered into that certain Amendment No. 1 to Intellectual Property License Agreement (“Amendment No. 1”) with BP United Inc. (“BP United”), which amends that certain Intellectual Property License Agreement, dated as of May 12, 2026, between the Company and BP United (the “IP Agreement”).”

MARAVAI LIFESCIENCES HOLDINGS, INC. terminated Prior Credit Agreement with Morgan Stanley Senior Funding, Inc. (effective 2026-06-02).

“On June 2, 2026, the parties terminated the Prior Credit Agreement in connection with the Borrower’s prepayment in full of all outstanding borrowings and accrued interest thereunder.”

MARAVAI LIFESCIENCES HOLDINGS, INC. entered into New Credit Agreement with certain lenders and issuing banks valued at $150.0 million term loan facility and a $30.0 million revolving credit facility (effective 2026-06-02).

“On June 2, 2026, Maravai Intermediate Holdings, LLC (the “Borrower”) and Maravai Topco Holdings, LLC (“Topco”), each a consolidated subsidiary controlled by Maravai LifeSciences Holdings, Inc., entered into a Credit Agreement (the “New Credit Agreement”) with certain lenders and issuing banks party thereto and BSP Agency, LLC, as administrative agent and collateral agent.”

Empery Digital Inc. amended Amendment No. 2 and Waiver to the At-The-Market Issuance Sales Agreement with Aegis Capital Corp. valued at Extends the term of the At-The-Market Issuance Sales Agreement until issuance and sale of all shares (effective 2026-06-02).

“Item 1.01 Entry Into a Material Definitive Agreement. Amendment of At-The-Market Issuance Sales Agreement On June 2, 2026, Empery Digital Inc. (the “ Company ”) entered into Amendment No. 2 and Waiver to the At-The-Market Issuance Sales Agreement (the “ ATM Amendment ”) with Aegis Capital Corp. (“ Aegis ”) which, among other matters, extends the term of the At-The-Market Issuance Sales Agreement dated October 18, 2024, between the Company and Aegis, as amended, such that, unless earlier terminated by one of the parties thereto, it will automatically terminate upon the issuance and sale of all of the shares authorized thereunder.”

ENERGY FOCUS, INC/DE entered into Purchase Agreement with Euka Power Japan Co., Ltd. valued at $250,000 (effective 2026-05-29).

“On May 29, 2026 , Energy Focus, Inc., a Delaware corporation (the “Company”) entered into a securities purchase agreement (the “Purchase Agreement”) with Euka Power Japan Co., Ltd. (the “Purchaser”), pursuant to which the Company agreed to issue and sell in a private placement (the “Private Placement”) an aggregate of 65,789 shares (the “Shares”) of the Company’s common stock, par value $0.0001 per share (the “Common Stock”), for a purchase price per share of $3.80, the closing price of the Common Stock on the day immediately preceding the date of the Purchase Agreement, totaling $250,000.”

ARCH CAPITAL GROUP LTD. entered into Underwriting Agreement with the underwriters named therein valued at $600,000,000 aggregate principal amount of 5.250% senior notes due 2036 and $1,400,000,000 aggregate (effective 2026-06-02).

“On June 2, 2026, Arch Capital Group Ltd. (“ACGL” or the “Issuer”) entered into an Underwriting Agreement pursuant to which the Issuer agreed to sell, and the underwriters named therein agreed to purchase, subject to and upon terms and conditions set forth therein, (i) $600,000,000 aggregate principal amount of 5.250% senior notes due 2036 (the “2036 Notes”) and (ii) $1,400,000,000 aggregate principal amount of 5.950% senior notes due 2056 (the “2056 Notes” and, together with the 2036 Notes, the “Notes”).”

Mineralys Therapeutics, Inc. entered into Senior Secured Term Loan Agreement with BioPharma Credit PLC valued at Up to $500,000,000 in term loans (effective 2026-06-02).

“On June 2, 2026 (the “Closing Date”), the Company entered into a senior secured term loan agreement (the “Loan Agreement”) with BioPharma Credit PLC, as collateral agent (the “Agent”), and each of BPCR Limited Partnership and BioPharma Credit Investments V (Master) LP, which are funds managed by Pharmakon Advisors, LP, as lenders.”

ASTROTECH Corp entered into Offering Agreement with H.C. Wainwright & Co., LLC valued at up to $24,492,819 (effective 2026-06-02).

“On June 2, 2026, Astrotech Corporation (the “Company”), entered into an at-the-market offering agreement (the “Offering Agreement”) with H.C. Wainwright & Co., LLC, as agent (“Wainwright”), pursuant to which the Company may offer and sell, from time to time through Wainwright shares of the Company’s common stock, par value $0.001 per share (the “Common Stock”), having an aggregate offering price of up to $24,492,819 (the “Shares”).”